These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4796282)

  • 21. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract]   [Full Text] [Related]  

  • 22. Considerations for the pre-clinical evaluation of new psychiatric drugs: a case study with phenothiazine-like tranquilizers.
    Irwin S
    Psychopharmacologia; 1966; 9(4):259-87. PubMed ID: 6011791
    [No Abstract]   [Full Text] [Related]  

  • 23. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 24. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain.
    Costall B; Naylor RJ; Olley JE
    Neuropharmacology; 1972 Sep; 11(5):645-63. PubMed ID: 4597256
    [No Abstract]   [Full Text] [Related]  

  • 25. Intrastriatal injection of quaternary butyrophenones and oxypertine: neuroleptic effect in rats.
    Fog R; Randrup A; Pakkenberg H
    Psychopharmacologia; 1971; 19(3):224-30. PubMed ID: 5105727
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the electrophysiological effects of two neuroleptics, melperone and thioridazine, on isolated rat atria.
    Refsum H; Passwal M; Olsson SO
    Eur J Pharmacol; 1978 Jun; 49(3):285-93. PubMed ID: 658142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the extrapyramidal system from the standpoint of pharmacology and psychopharmacology].
    Hara S
    Zasshi Tokyo Ika Daigaku; 1969 Jan; 27(1):1-22. PubMed ID: 4978901
    [No Abstract]   [Full Text] [Related]  

  • 28. Sulman FG: Mammotropic and neuroleptic effects of butyrophenones in the rat.
    Mishkinsky J; Khazen K; Givant Y; Dikstein S
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):94-105. PubMed ID: 5388566
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C; Merlis S
    Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862
    [No Abstract]   [Full Text] [Related]  

  • 30. The purely neuroleptic effects and its relation to the "neuroleptic threshold".
    Haase HJ
    Acta Psychiatr Belg; 1978; 78(1):19-36. PubMed ID: 645405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine-induced increases in dopaminergic single cell firing rate after haloperidol pretreatment. Correlation with extrapyramidal side effects.
    Welch JJ; Kim HS; Liebman J
    Neuropharmacology; 1980 Apr; 19(4):371-7. PubMed ID: 7383282
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose calibration studies of lenperone, a new tranquilizer for dogs, cats and swine.
    Cloyd GD; Gilbert DL
    Vet Med Small Anim Clin; 1973 Apr; 68(4):344 passim. PubMed ID: 4487932
    [No Abstract]   [Full Text] [Related]  

  • 33. [Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
    Stille G
    Schweiz Med Wochenschr; 1969 Nov; 99(46):1645-52 contd. PubMed ID: 4391348
    [No Abstract]   [Full Text] [Related]  

  • 34. The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Verbruggen FJ; van Nueten JM; Marsboom RH; Hérin VV; Schaper WK
    Arzneimittelforschung; 1970 Nov; 20(11):1689-98. PubMed ID: 4992598
    [No Abstract]   [Full Text] [Related]  

  • 35. delta9-Tetrahydrocannabinol and the extrapyramidal system.
    Gough AL; Olley JE
    Psychopharmacology (Berl); 1977 Aug; 54(1):87-99. PubMed ID: 410052
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):418-29. PubMed ID: 576565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
    Rolinski Z; Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):385-99. PubMed ID: 4149038
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of various neuroleptic drugs on shock avoidance responding in rats. II. Nondiscriminated Sidman avoidance procedure with alternate reinforcement and extinction periods and analysis of the interresponse times (IRT's).
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1969; 16(3):175-82. PubMed ID: 5391696
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of various neuroleptic drugs on shock avoidance responding in rats. 3. Amphetamine antagonism in the discriminated Sidman avoidance procedure.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1970; 17(2):151-9. PubMed ID: 5443882
    [No Abstract]   [Full Text] [Related]  

  • 40. Extrapyramidal modification of fine movements: a "conditio sine qua non" of the fundamental therapeutic action of neuroleptic drugs.
    HAASE HJ
    Rev Can Biol; 1961 Jun; 20():425-49. PubMed ID: 13903363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.